(Q38856131)

English

ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer

scientific article published on 3 July 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

author name string

Pei Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Shuwen Yu

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Hongyu Li

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Chuanyong Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Juan Li

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Wenli Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Aiqin Gao

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Linlin Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Wei Gao

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yuping Sun

10

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

0 references

publication date

3 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

589

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

2248-2256

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Cancer treatment and survivorship statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Global cancer patterns: causes and prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Expression of Ig-like transcript 4 inhibitory receptor in human non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

B7 family checkpoint regulators in immune regulation and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

The expression, function, and clinical relevance of B7 family members in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Diagnosis value of serum B7-H3 expression in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

B7-h3 and its role in antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

B7-H3-mediated tumor immunology: Friend or foe?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

The B7 family and cancer therapy: costimulation and coinhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

B7-H3 and B7-H4 expression in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Hypoxia-induced SM22α in A549 cells activates the IGF1R/PI3K/Akt pathway, conferring cellular resistance against chemo- and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2015.06.037

21 January 2018

Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer

1 reference

https://opencitations.net/index/api/v1/citations/10.3892/OL.2013.1586

12 January 2024

Identifiers

10.1016/J.FEBSLET.2015.06.037

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38856131&oldid=2052614788"